Gastrointestinal Cancers Symposium

The latest news from ASCO GI, including researcher interviews and physician perspective.


Meeting News CoverageMeeting Highlights

FDG-PET identified early response to chemotherapy in rare esophageal cancer

HemOnc Today, February 10, 2011
2011 Gastrointestinal Cancers Symposium FDG-PET imaging detected early metabolic response to chemotherapy in patients with locally advanced…
Meeting News CoverageMeeting HighlightsPerspective

IMRT produced less toxicity, similar outcomes as conventional radiation in anal cancer

HemOnc Today, February 10, 2011
2011 Gastrointestinal Cancers Symposium SAN FRANCISCO — Chemotherapy with dose-painted intensity-modulated radiation therapy for anal cancer…
Meeting News CoverageMeeting Highlights

Sorafenib viable option in treating drug-resistant GIST

HemOnc Today, February 10, 2011
2011 Gastrointestinal Cancers Symposium SAN FRANCISCO — Sorafenib appears to be a viable treatment option for patients with gastrointestinal…
Meeting News CoverageMeeting Highlights

SWOG 0356: High gene-expression ERCC1 levels predicted poorer survival

HemOnc Today, February 10, 2011
2011 Gastrointestinal Cancers Symposium SAN FRANCISCO — Patients with stage II to III esophageal adenocarcinoma who had elevated levels of ERCC1…
Meeting News CoveragePerspective

START: S-1 plus docetaxel improved survival in subset of patients with advanced gastric cancer

January 21, 2011
2011 Gastrointestinal Cancers Symposium SAN FRANCISCO — The combination of S-1 plus docetaxel failed to meet the primary endpoint of 25%…
Meeting News Coverage

Gene test may identify recurrence risk for stage II colorectal cancer

January 20, 2011
2011 Gastrointestinal Cancers Symposium A gene expression test was able to predict which patients with stage II colorectal cancer were most…